Based on the patented MSRRS sensor technology, biozoom has succeeded in measuring important biomarkers non-invasively through the skin. Previously, important biomarkers could only be measured by taking blood samples and cost-intensive lab analysis. With the new sensor, biomarkers can be measured within seconds by placing the palm onto an optical sensor. The optical parameters are recorded by the palm sized scanner and sent to a central server by internet connection. There sophisticated algorithms perform the quantitative and qualitative evaluation and return the current level of the user’s biomarkers. Within a few seconds, the user receives the medically validated measurement result on his smartphone where it is explained and interpreted. In addition, recommendations are issued to improve his results and well-being.

​

The main advantage of a central evaluation is copy protection. Competitors can buy the scanner and analyze the hardware, but they have no access to the intelligent data processing and evaluation algorithms. Another positive side effect is, that the server-based service allows different business models. Frequency of use and expandable features (for example additional biomarkers) can individually be billed online. The amount of anonymous health data collected in this way worldwide is invaluable.  On the basis of this data, new algorithms can be developed and validated a posteriori.

​

​